<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03822676</url>
  </required_header>
  <id_info>
    <org_study_id>ZS-1833</org_study_id>
    <nct_id>NCT03822676</nct_id>
  </id_info>
  <brief_title>Prophylactic Pancreatic Stent for the Prevention of Post Operative Pancreatic Fistula</brief_title>
  <official_title>Prophylactic Pancreatic Stent for the Prevention of Post Operative Pancreatic Fistula Before Segmental Pancreatectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Peking Union Medical College Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Peking Union Medical College Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Postoperative pancreatic fistula (POPF) remains one of the most harmful complications after
      pancreatic resection. Some studies have indicated that endoscopic pancreatic stenting was
      effective in the treatment of POPF. However, the results of prospective RCTs for the
      prophylactic effect of pancreatic stent insertion against POPF were controversial. This
      single center prospective randomized trial was designed to compare the outcome after
      segmental pancreatectomy with prophylactic drainage stent versus no stent.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 22, 2019</start_date>
  <completion_date type="Anticipated">May 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Postoperative pancreatic fistula</measure>
    <time_frame>from postoperative day 3 to 30</time_frame>
    <description>Grade B and C</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Severity of pancreatic fistula</measure>
    <time_frame>from postoperative day 3 to 30</time_frame>
    <description>Grade B POPF requires changes in clinical management, such as persistent drainage, partial or total parenteral nutrition, antibiotics, enteral nutrition, somatostatin analogs, and/or minimal invasive drainage. Grade C POPF requires major changes in management, such as admission to an intensive care unit, reoperation, and/or an extended hospital stay.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of stay</measure>
    <time_frame>from postoperative day 1 to discharge</time_frame>
    <description>Length of hospital stay</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">38</enrollment>
  <condition>Pancreatic Fistula</condition>
  <arm_group>
    <arm_group_label>Stent</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Prophylactic pancreatic stent before segmental pancreatic surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No stent</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No prophylactic stent before surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Prophylactic pancreatic stent</intervention_name>
    <description>Prophylactic pancreatic stent before segmental pancreatic surgery</description>
    <arm_group_label>Stent</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All patients scheduled for elective segmental pancreatectomy

        Exclusion Criteria:

          -  Subjects for whom ERCP procedures are contraindicated

          -  If female, pregnant based on a positive hCG serum or an in vitro diagnostic test
             result or breast-feeding

          -  Age less than 18 year

          -  Emergency surgery

          -  Previous pancreatic surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Peking Union Medical College Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100730</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aiming Yang, M.D.</last_name>
      <phone>+86-10-69151593</phone>
      <email>yangaiming@medmail.com.cn</email>
    </contact>
    <investigator>
      <last_name>Yunlu Feng, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>January 2019</verification_date>
  <study_first_submitted>January 28, 2019</study_first_submitted>
  <study_first_submitted_qc>January 28, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">January 30, 2019</study_first_posted>
  <last_update_submitted>January 28, 2019</last_update_submitted>
  <last_update_submitted_qc>January 28, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">January 30, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pancreatic Fistula</mesh_term>
    <mesh_term>Fistula</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

